Efficacy evaluation of a CRACM1 inhibitor, Ro2959, in a hu scid mouse xenogenic graft versus host disease model
|Effective start/end date||11/29/10 → 11/28/11|
- HOFFMANN-LA ROCHE PHARMACEUTICALS
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.